- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 20M: N-(4-{[4-(pyrrolidin-1-yl)piperidin-1-yl]sulfonyl}benzyl)-2H-pyrido[4,3-e][1,2,4]thiadiazin-3-amine 1,1-dioxide(Non-covalent)
- 6 x PO4: PHOSPHATE ION(Non-functional Binders)
- PO4.2: 7 residues within 4Å:- Chain A: R.196, E.246, H.247, R.311, D.313
- Chain B: Y.18
- Ligands: PO4.12
 14 PLIP interactions:11 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:H.247, A:D.313, B:Y.18
- Water bridges: A:R.196, A:R.196, A:R.196, A:H.247, A:S.248, A:R.311, B:E.149, B:K.400
- Salt bridges: A:R.196, A:H.247, A:R.311
 - PO4.3: 6 residues within 4Å:- Chain A: R.392, S.398, K.400
- Chain B: R.196
- Ligands: EDO.6, PO4.13
 12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:S.398, A:S.398, B:R.196
- Water bridges: A:R.392, A:R.392, A:F.399, A:K.400, A:K.415, A:K.423, A:K.423
- Salt bridges: A:R.392, A:K.400
 - PO4.4: 8 residues within 4Å:- Chain A: F.193, G.194, R.196, G.197, G.383, G.384
- Chain B: R.392
- Ligands: EDO.10
 10 PLIP interactions:5 interactions with chain A, 5 interactions with chain B- Hydrogen bonds: A:F.193, A:G.197, A:G.384
- Water bridges: A:F.193, A:G.385, B:R.392, B:R.392, B:R.392, B:R.392
- Salt bridges: B:R.392
 - PO4.12: 6 residues within 4Å:- Chain A: R.196
- Chain B: R.392, S.398, K.400
- Ligands: PO4.2, EDO.15
 18 PLIP interactions:15 interactions with chain B, 3 interactions with chain A- Water bridges: B:E.149, B:R.392, B:R.392, B:R.392, B:F.399, B:F.399, B:K.400, B:K.400, B:K.415, B:K.415, B:K.415, B:K.423, B:K.423, A:D.313, A:D.354
- Salt bridges: B:R.392, B:K.400
- Hydrogen bonds: A:R.196
 - PO4.13: 7 residues within 4Å:- Chain A: Y.18
- Chain B: R.196, E.246, H.247, R.311, D.313
- Ligands: PO4.3
 14 PLIP interactions:4 interactions with chain A, 10 interactions with chain B- Hydrogen bonds: A:Y.18, B:H.247
- Water bridges: A:K.400, A:K.400, A:K.400, B:R.196, B:R.196, B:R.196, B:R.196, B:S.248, B:R.311
- Salt bridges: B:R.196, B:H.247, B:R.311
 - PO4.14: 8 residues within 4Å:- Chain A: R.392
- Chain B: F.193, G.194, R.196, G.197, G.383, G.384
- Ligands: EDO.18
 8 PLIP interactions:3 interactions with chain B, 5 interactions with chain A- Hydrogen bonds: B:G.197, B:G.384
- Water bridges: B:G.385, A:R.392, A:R.392, A:R.392, A:R.392
- Salt bridges: A:R.392
 
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- EDO.5: 7 residues within 4Å:- Chain A: K.169, E.187, V.213, N.214, F.215, K.216, R.477
 4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.187, A:E.187, A:V.213
- Water bridges: A:K.216
 - EDO.6: 7 residues within 4Å:- Chain A: R.40, R.392, D.393, N.396, C.397, S.398
- Ligands: PO4.3
 7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:R.40, A:R.40, A:D.393, A:D.393, A:N.396, A:S.398, A:S.398
 - EDO.7: 7 residues within 4Å:- Chain A: K.189, I.309, R.349, V.350, I.378, A.379
- Ligands: 20M.1
 4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.189, A:K.189, A:V.350, A:A.379
 - EDO.8: 5 residues within 4Å:- Chain A: G.315, P.317, D.354, G.355
- Ligands: EDO.17
 1 PLIP interactions:1 interactions with chain A- Water bridges: A:G.355
 - EDO.9: 6 residues within 4Å:- Chain A: G.122, F.123, V.124, R.434, F.440, N.479
 3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.122, A:V.124, A:R.434
 - EDO.10: 5 residues within 4Å:- Chain A: G.353, D.354, G.355, G.384
- Ligands: PO4.4
 12 PLIP interactions:6 interactions with chain B, 6 interactions with chain A- Water bridges: B:R.392, B:R.392, B:R.392, B:R.392, B:D.393, B:D.393, A:V.356, A:G.385
- Hydrogen bonds: A:D.354, A:D.354, A:G.355, A:G.384
 - EDO.15: 8 residues within 4Å:- Chain B: R.40, R.392, D.393, N.396, C.397, S.398
- Ligands: PO4.12, EDO.17
 7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:R.40, B:R.40, B:D.393, B:D.393, B:N.396, B:S.398, B:S.398
 - EDO.16: 8 residues within 4Å:- Chain A: H.247, S.248, T.251
- Chain B: K.400, C.401, F.414, K.415, S.425
 6 PLIP interactions:2 interactions with chain A, 4 interactions with chain B- Water bridges: A:E.246, A:S.248, B:N.146, B:C.401, B:V.413
- Hydrogen bonds: B:C.401
 - EDO.17: 6 residues within 4Å:- Chain B: R.40, D.393, N.396, K.423
- Ligands: EDO.8, EDO.15
 4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.40, B:K.423, B:K.423
- Water bridges: B:N.396
 - EDO.18: 5 residues within 4Å:- Chain B: G.353, D.354, G.355, G.384
- Ligands: PO4.14
 9 PLIP interactions:4 interactions with chain A, 5 interactions with chain B- Water bridges: A:R.392, A:R.392, A:R.392, A:D.393, B:V.356, B:G.385
- Hydrogen bonds: B:D.354, B:G.355, B:G.384
 - EDO.19: 8 residues within 4Å:- Chain A: K.400, C.401, F.414, K.415, S.425
- Chain B: H.247, S.248, T.251
 8 PLIP interactions:4 interactions with chain B, 4 interactions with chain A- Hydrogen bonds: B:T.251, A:C.401
- Water bridges: B:E.246, B:E.246, B:S.248, A:N.146, A:C.401, A:V.413
 - EDO.20: 6 residues within 4Å:- Chain A: Y.195, A.222
- Chain B: F.9, N.10, L.13, A.14
 4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:E.8, B:N.10, B:L.13, A:Y.195
 
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zheng, X. et al., Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorg.Med.Chem.Lett. (2013)
            
- Release Date
- 2013-09-25
- Peptides
- Nicotinamide phosphoribosyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
 PDB Chain Id:A
 AB
 B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 20M: N-(4-{[4-(pyrrolidin-1-yl)piperidin-1-yl]sulfonyl}benzyl)-2H-pyrido[4,3-e][1,2,4]thiadiazin-3-amine 1,1-dioxide(Non-covalent)
- 6 x PO4: PHOSPHATE ION(Non-functional Binders)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zheng, X. et al., Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorg.Med.Chem.Lett. (2013)
            
- Release Date
- 2013-09-25
- Peptides
- Nicotinamide phosphoribosyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
 PDB Chain Id:A
 AB
 B